New Pharmacotherapy Targeting Cognitive Dysfunction of Schizophrenia via Modulation of GABA Neuronal Function

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|13|6|793-801

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.13, Iss.6, 2015-12, pp. : 793-801

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia

By  

Current Neuropharmacology, Vol. 3, Iss. 1, 2005-01 ,pp. : 45-62

Bentham Science Publishers

Access to resources Recommend Favorite

Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia

By Castner Stacy   Goldman-Rakic Patricia   Williams Graham  

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 111-125

Springer Publishing Company

Access to resources Recommend Favorite

Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction

By Goldman-Rakic Patricia   Castner Stacy   Svensson Torgny   Siever Larry   Williams Graham  

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 3-16

Springer Publishing Company

Access to resources Recommend Favorite

Cognitive Dysfunction in Bipolar Disorder: Future Place of Pharmacotherapy

By Burdick Katherine E.   Braga Raphael J.  

CNS Drugs, Vol. 21, Iss. 12, 2007-01 ,pp. : 971-981

Adis International

Access to resources Recommend Favorite

Pharmacological Approaches to the Management of Cognitive Dysfunction in Schizophrenia

By Harvey Philip D.  

Drugs, Vol. 66, Iss. 11, 2006-01 ,pp. : 1465-1473

Adis International

Access to resources Recommend Favorite